KYDRAZZA

Welcome to the Brand page for “KYDRAZZA”, which is offered here for Pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (fsgs); pharmaceutical preparations for the treatment of immunoglobulin a nephropathy (igan); pharmaceutical preparations for the treatment of alport syndrome;.

Its status is currently believed to be active. Its class is unavailable. “KYDRAZZA” is believed to be currently owned by “TRAVERE THERAPEUTICS, INC.”